Work

Clinical and out-of-pocket cost outcomes after switching to biosimilar adalimumab-atto in patients with rheumatoid arthritis

Year: 2025

Type: article

Study design: Observational Study

Source: Expert Opinion on Biological Therapy

DOI: 10.1080/14712598.2025.2574011

Authors: Antony T-H Lin, Fang Niu, Rita L. Hui, Abbey Londa, Catherine Pham, Samantha Teshima, Thomas Delate

Institutions: Kaiser Permanente, Kaiser Permanente Northern California

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415020352

FWCI:

Cites: 22

Cited by:

Related to: